eFFECTOR Therapeutics (EM)【EFTR】銘柄情報

eFFECTOR Therapeutics Inc (EM) (EFTR) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.0002

( - )

買値

0.00

売値

0.00

出来高

0.00 日の範囲 0.00

0.0002 52 週間の範囲 0.02

時価総額

940.882

前日終値

0.0002

始値

時刻

0.0002

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

US$ 3,705

発行済株式数

4,704,409

配当利回り

PER

-0

1 株当たり利益 (EPS)

-12.41

歳入

純利益

-34.63M

eFFECTOR Therapeutics, Inc., a biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. The company’s lead product candidate includes Zotatifin, an inhibitor of eIF4A, which is in Phase 1/2 clinical trial to treat patients with ... eFFECTOR Therapeutics, Inc., a biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. The company’s lead product candidate includes Zotatifin, an inhibitor of eIF4A, which is in Phase 1/2 clinical trial to treat patients with solid tumors, as well as has completed Phase 2 clinical trial in combination with fulvestrant and abemaciclib to treat patients with ER+ breast cancer. It also develops Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. It has a research collaboration and license agreement with Pfizer Inc. to research and develop small molecules that target eIF4E. eFFECTOR Therapeutics, Inc. was founded in 2012 and is headquartered in Solana Beach, California. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

effector.com

本社

Solana Beach, United States

設立

2026

eFFECTOR Therapeutics Inc (EM) is listed in the Healthcare sector of the その他OTC with ticker EFTR. The last closing price for eFFECTOR Therapeutics (EM) was US$0. Over the last year, eFFECTOR Therapeutics (EM) shares have traded in a share price range of US$ 0.0002 to US$ 0.02.

eFFECTOR Therapeutics (EM) currently has 4,704,409 shares in issue. The market capitalisation of eFFECTOR Therapeutics (EM) is US$940.88 . eFFECTOR Therapeutics (EM) has a price to earnings ratio (PE ratio) of -0.00.

Form EFFECT - Notice of Effectiveness

Form 15-12G - Securities registration termination [Section 12(g)]

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form POS AM - Post-Effective amendments for registration statement

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.0002	0.0006	0.0002	554	0.00027465	CS
4	0	0	0.0002	0.0006	0.0002	1127	0.00040589	CS
12	0	0	0.0002	0.0006	0.0002	3521	0.0004413	CS
26	0	0	0.0002	0.01	0.0002	5468	0.00028085	CS
52	0	0	0.0002	0.02	0.0002	4659	0.00036112	CS
156	-0.0998	-99.8	0.1	0.17	1.0E-6	25947	0.04913212	CS
260	-0.0998	-99.8	0.1	0.17	1.0E-6	25947	0.04913212	CS